Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19

Abstract The present Perspective examined the latest evidence on the association between the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) and the incidence/mortality of coronavirus disease 2019 (COVID‐19). Our critical appraisal from existing litera...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Martin C.S. Wong, Sunny Wong, Junjie Huang, Bryan Yan
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Oxford University Press 2020-10-01
Rangatū:	ESC Heart Failure
Ngā marau:	COVID‐19 Angiotensin‐converting enzyme inhibitor Angiotensin receptor blocker Severity Mortality
Urunga tuihono:	https://doi.org/10.1002/ehf2.12952
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!